The widespread utilization of prostate-specific antigen (PSA) testing has fundamentally altered the landscape of prostate cancer detection, contributing to an increased frequency of diagnoses at earlier, localized stages, particularly among younger individuals. The gene discussed is KLK3; the disease is prostate cancer.